BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20635203)

  • 21. Bayesian semiparametric intensity estimation for inhomogeneous spatial point processes.
    Yue YR; Loh JM
    Biometrics; 2011 Sep; 67(3):937-46. PubMed ID: 21175553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very fast algorithms for evaluating the stability of ML and Bayesian phylogenetic trees from sequence data.
    Waddell PJ; Kishino H; Ota R
    Genome Inform; 2002; 13():82-92. PubMed ID: 14571377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian mixture modeling using a hybrid sampler with application to protein subfamily identification.
    Fong Y; Wakefield J; Rice K
    Biostatistics; 2010 Jan; 11(1):18-33. PubMed ID: 19696187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phylogenetic MCMC algorithms are misleading on mixtures of trees.
    Mossel E; Vigoda E
    Science; 2005 Sep; 309(5744):2207-9. PubMed ID: 16195459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating survival curves with left-truncated and interval-censored data under monotone hazards.
    Pan W; Chappell R
    Biometrics; 1998 Sep; 54(3):1053-60. PubMed ID: 9750251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifiability of parameters in MCMC Bayesian inference of phylogeny.
    Rannala B
    Syst Biol; 2002 Oct; 51(5):754-60. PubMed ID: 12396589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parametric bootstrap for testing model fitting in the proportional hazards framework: an application to the survival analysis of Bruna dels Pirineus beef calves.
    Casellas J; Tarrés J; Piedrafita J; Varona L
    J Anim Sci; 2006 Oct; 84(10):2609-16. PubMed ID: 16971560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A two-component model for counts of infectious diseases.
    Held L; Hofmann M; Höhle M; Schmid V
    Biostatistics; 2006 Jul; 7(3):422-37. PubMed ID: 16407470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Bayesian approach to competing risks analysis with masked cause of death.
    Sen A; Banerjee M; Li Y; Noone AM
    Stat Med; 2010 Jul; 29(16):1681-95. PubMed ID: 20575048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A general framework for random effects survival analysis in the Cox proportional hazards setting.
    Sargent DJ
    Biometrics; 1998 Dec; 54(4):1486-97. PubMed ID: 9883547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABC: a useful Bayesian tool for the analysis of population data.
    Lopes JS; Beaumont MA
    Infect Genet Evol; 2010 Aug; 10(6):826-33. PubMed ID: 19879976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural network models for conditional distribution under bayesian analysis.
    Miazhynskaia T; Frühwirth-Schnatter S; Dorffner G
    Neural Comput; 2008 Feb; 20(2):504-22. PubMed ID: 18045023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smooth estimation of survival functions and hazard ratios from interval-censored data using Bayesian penalized B-splines.
    Çetinyürek Yavuz A; Lambert P
    Stat Med; 2011 Jan; 30(1):75-90. PubMed ID: 20963752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empirical Markov Chain Monte Carlo Bayesian analysis of fMRI data.
    de Pasquale F; Del Gratta C; Romani GL
    Neuroimage; 2008 Aug; 42(1):99-111. PubMed ID: 18538586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the demand for health care with panel data: a semiparametric Bayesian approach.
    Jochmann M; León-González R
    Health Econ; 2004 Oct; 13(10):1003-14. PubMed ID: 15455465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory Bayesian model selection for serial genetics data.
    Zhao JX; Foulkes AS; George EI
    Biometrics; 2005 Jun; 61(2):591-9. PubMed ID: 16011709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian modeling of multiple lesion onset and growth from interval-censored data.
    Dunson DB; Holloman C; Calder C; Gunn LH
    Biometrics; 2004 Sep; 60(3):676-83. PubMed ID: 15339290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of a Bayesian approach to the analysis of a complex, mechanistically based model.
    Jonsson F; Jonsson EN; Bois FY; Marshall S
    J Biopharm Stat; 2007; 17(1):65-92. PubMed ID: 17219756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical inference for stochastic simulation models--theory and application.
    Hartig F; Calabrese JM; Reineking B; Wiegand T; Huth A
    Ecol Lett; 2011 Aug; 14(8):816-27. PubMed ID: 21679289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.